On May 17, Mr. Sheng Licheng, Party Branch Secretary of the Beijing Yicheng Cooperation and Development Foundation, along with Executive Secretary General Wang Rude, Deputy Secretary General Ren Yi, and Deputy Director of Development Department Dai Miao, visited Beijing tricision Biotech Co., Ltd. for guidance and inspection. The tricision team—including founding shareholder Lan Baoshi, CTO Dr. Li Shiyou, Executive Vice President Zhao Xi, and CFO Luo Zhijun—accompanied the visit and participated in discussions.

The foundation leaders toured the company's vaccine R&D center, where Dr. Li Shiyou presented tricision's mRNA vaccine technological innovation and R&D production.

The foundation leaders toured the company's vaccine R&D center, where Dr. Li Shiyou presented tricision's mRNA vaccine technological innovation and R&D production. During the symposium, Secretary Sheng listened carefully to tricision's technological features and R&D progress in the mRNA vaccine field, engaging in interactive discussions covering key vaccine development technologies, intellectual property landscape, and industrialization strategy. Secretary Sheng highly praised tricision's achievements and progress, noting that the global pandemic continues and that the world's hope for ultimately defeating the virus rests largely on successful vaccine development. He encouraged the company to seize the "window of opportunity" to accelerate research efforts, strengthen R&D intensity, and safeguard public health. He also expressed hope that this visit would establish mutual trust between the two parties and facilitate deeper cooperation to promote high-quality development.

Beijing tricision Biotech Co., Ltd., founded in 2015, is a biopharmaceutical enterprise focused on innovative R&D and product development of mRNA information drugs. Its wholly-owned subsidiary, tricision Biotech (Zhuhai) Co., Ltd., was established in 2018. tricision upholds the mission of "protecting human life and health through nucleic acid information technology" with the goal of "building a leading integrated mRNA platform."

The Beijing Yicheng Cooperation and Development Foundation, approved by the Beijing Municipal Civil Affairs Bureau in October 2020 under the supervision of the Beijing Economic-Technological Development Area Administrative Committee, engages in charitable activities including supporting disadvantaged individuals, non-profit projects in science, education, culture, health, sports, and environmental protection, and disaster relief.